Purpose: Intracytoplasmic sperm injection (ICSI) guarantees high fertilization rates and could theoretically lead to
INTRODUCTION
Since intracytoplasmic sperm injection (ICSI) was first reported in 1992 (1), numerous reports of high success rates with the use of ICSI (2-4) followed. ICSI has become the treatment of choice for male factor infertility. In their study Mansour et al. (4) have reported that fertilization and pregnancy rates are not affected by different semen parameters as long as morphologically well shaped live sperm could be used for the injection. ICSI guarantees high fertilization rates. Theoretically it could lead to higher implantation rates as well since injection into oocyte creates a hole in the zona pellucida similar to the procedure of assisted hatching. In their study Cohen et al. (5) previously showed that assisted hatching improves the implantation and pregnancy rates in conventional IVF. Considering the fact that ICSI may assist the hatching process, we made the assumption that ICSI might offer better results for nonmale factor patients. In previous experience a pregnancy rate of 39% was achieved with the ICSI technique (6). This was a higher pregnancy rate than that of conventional IVF for patients for whom a male factor was not present, which confirm the experience of the pioneer group in ICSI technique in Brussels (2). Our objective was to investigate whether after ICSI the quality of embryos is better than that of embryos after conventional IVF. Furthermore we assessed differences in ongoing pregnancy rates and miscarriage rates between ICSI and conventional IVF.
MATERIALS
This open randomized prospective study was designed according to the rules of "good clinical practise" (GCP) with informed consent of the patients and institutional review board approval.
The patients were randomly divided into two study groups. In Group I ICSI was performed on all mature oocytes. This group was then compared with patients who underwent conventional IVF (Group II). The inclusion criteria included mean age between 18 and 39 years; confirmed tuboperitoneal factor infertility; normal uterine cavity confirmed at hydrosalpingography and/or hysteroscopy; regular menstrual cycle every 22-35 days; cycle Day 3 serum FSH, E2, prolactin, and TSH levels within normal limits. The male partners of the patients had normal semen analyses according to World Health Organization criteria (7) ≤6 months before the study. In addition, their sperm morphology was normal according to strict criteria (8) . All patients were stimulated with the same protocol, using the GnRH-a buserelin acetate in an ultrashort flair-up protocol together with pure follicle stimulating hormone (FSH) (Purgon ® = Follistim ® , Organon, Oss, Holland), 100-150 international units (IU) per day. Baseline hormone levels (FSH, LH, E2, HPRL, DHEAS) were determined on the first stimulation day. Ovulation was initiated using HCG, 10.000 IU and on the same day estradiol level was measured in all cases. Transvaginal ultrasound-guided follicle aspiration was performed 36 h later. ICSI procedure was performed 4-6 h after retrieval. Survival and fertilization were determined 14-16 h after injection. In case of conventional IVF one or two drops of semen, dependent on the semen density, (3 million = 2 drops; 5 million = 1 drop) were added to oocytes. Embryos were then graded according to a standard score (9) . Embryos were transferred to the uterus approximately 42 h after the ICSI procedure or insemination. Any remaining embryos were cryopreserved according to a standard method (10) .
The two groups were compared in regard to clinical pregnancy rates, implantation rate (fetal heartbeats seen on ultrasound per transferred embryo at 8-week gestation), fertilization rate, age, BMI, baseline (Day 2-3) hormone levels, for example, E2, FSH, LH, HPRL, DHEAS, endometrium thickness, em- 
RESULTS
Ninety-one patients were included in this open randomized prospective study. A total of 45 conventional IVF cycles and 44 ICSI cycles remained for calculation. In addition two rescue ICSIs had to be performed because no fertilization could be detected in these patients after the day of insemination.
Three patients had no ET but all generated embryos were cryopreserved. One patient had an increased potential risk of ovarian hyperstimulation. The second patient had some fluid in the uterus cavity and the third patient had no fertilization after insemination even though ISCI was performed. No significant differences were observed between the two groups concerning the IVF variables: fertilization rate, age, body mass index, baseline hormone levels (Day 2-3) for example, FSH, LH, HPRL, E2, DHEAS, endometrial thickness, embryo score, and the highest embryo per transfer (Tables I and II) . The total pregnancy rate was 42% in the conventional IVF group with 33% ongoing pregnancies. The ICSI group had a total pregnancy rate of 39% with 23% ongoing pregnancies. a Impantation rate = fetal heart beat seen per transferred embryo as seen on ultrasound at 8 weeks of gestation.
The implantation rate per transferred embryo for normal IVF was higher than after ICSI (18% versus 11%; Table III ). In conventional IVF there were two sets of twins and one set of triplets even though in ICSI there was only one set of twins.
DISCUSSION
IVF has been offered as the first line of treatment for many tubal factor patients. However, for the past few years pregnancy rates for conventional IVF remained rather steady. The introduction of ICSI opened the door of male factor infertility. A high pregnancy rate and fertilization rate was achieved in ICSI for male factor patients (4) which is equal to the pregnancy rate for tubal factor patients with normal semen (11) . In their study Hamberger et al. (12) suggested that in the future ICSI should completely be replaced by conventional IVF because better pregnancy rate might be expected if normal spermatozoa were injected. Assisted hatching increases the implantation and pregnancy rates in conventional IVF (5) . In ICSI the penetration of zona pellucida is possible, which may assist the hatching process. These factors have led us to the assumption that ICSI might offer better results for nonmale factor patients. Van Streiteghem et al. (2) demonstrated higher pregnancy and implantation rates after transfer of embryos produced by ICSI for male factor couples than those after conventional IVF.
In a prospective randomized study Aboulghar et al. (13) and Bukulmez et al. (14) compared the results of IVF and ICSI in tubal factor infertility with normal semen parameters. No higher pregnancy could be demonstrated in ICSI compared with IVF in this study. The pregnancy rate was higher in patients with male factor compared to patients with tubal factor where ICSI was performed. The reasons for these results may be related to the fact that patients with male factor infertility tend to come at a younger age for IVF treatment. In contrast patients with tubal factor spend a number of years trying different conservative and surgical modalities of treatment. Besides that ICSI patients are usually healthy females with no pelvic pathology (13) . Molly et al. (15) reported that the presence of extensive adhesions reduces the pregnancy rate in conventional IVF. This could explain the differences between our conclusions and their conclusions. The outcome of ICSI varied depending on the indication for treatment. Patients with a history of failed or poor fertilization in vitro and with normal semen parameters had significantly lower pregnancy and implantation rates than patients with either obstructive azoospermia or impaired semen quality had (16) . On the other hand ICSI is the method of choice for patients with repeatedly negative pregnancy outcomes following conventional IVF (17) . Very often unexplained infertility is found in patients with mild endometriosis and in patients failing to conceive with intrauterine insemination (IUI). In these patients an 11.4% chance of fertilization failure has been observed after conventional IVF (18) . This can easily be overcome by using ICSI in at least some oocytes (19) . The results of the present work have shown that ICSI does not offer a higher pregnancy rate over conventional IVF in the treatment of tubal factor infertility, in case of normal semen. ICSI should be applied only when conventional IVF fails, that is, for male factor patients, for patients with unexplained infertility, and for patients with endometrioses (18) .
In some authors' opinion ICSI should be proceeded with caution in limiting the indications (20) . ICSI is a more expensive technique, it is time consuming, and it requires more equipment and extra skills. In addition to the invasive nature of the procedure, it is not superior to conventional IVF in this group of patients. We do not recommend using it for the treatment of tubal factor patients with normal semen.
